等待开盘 11-07 09:30:00 美东时间
+0.415
+1.38%
今日重点评级关注:Rosenblatt:维持SiTime"买入"评级,目标价从750美元升至900美元;花旗:维持Madrigal Pharmaceuticals"买入"评级,目标价从725美元升至760美元
11-04 18:17
TD Cowen analyst Andrew Sherman maintains NAPCO Security Techs (NASDAQ:NSSC) with a Buy and lowers the price target from $55 to $45.
11-03 23:53
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # Napco Security Technologies 2027财年第一季度业绩回顾摘要 ## 1. 财务业绩:**营收表现:** - 净营收5,000万美元,同比增长1.7%,创下第一季度历史纪录 - 经常性月度服务收入2,610万美元,同比增长11.5%,主要受StarLink无线通讯器持续激活驱动 - 年化经常性收入运行率约1.06亿美元,较2026年8月增加300万美元 - 设备收入2,390万美元,同比下降7.3%,主要因两家大型门锁经销商消化现有库存 - 入侵与门禁类产品整体下降1.8%,其中入侵产品销售增长1.7%,门禁产品销售下降
11-03 13:12
Napco Security Technologies, Inc. (NSSC) declares $0.17/share quarterly dividend, 13.3% increase from prior dividend of $0.15. Forward yield 1.82% Payable Oct. 2; for shareholders of record Sept. 11; ...
08-25 22:34
NAPCO Security Technologies Inc. (NASDAQ:NSSC) stock traded higher Monday after the security equipment maker reported better-than-expected fiscal fourth-quarter results. NAPCO posted adjusted earnings of 41 cents per share. That beat the analyst estimate of 39 cents. Quarterly revenue rose 10% year ...
08-24 23:34
Shares of Napco Security Technologies (NSSC) were up nearly 15% on Monday after the company posted quarterly results above Wall Street estimates. The company said its fourth-quarter net revenue increa...
08-24 21:49
纳普科安全技术(NSSC)2026财年第四季度业绩电话会:随着经常性收入运行率达到1.03亿美元,营收增长10%至5580万美元。
08-24 21:41
NAPCO Security Techs (NASDAQ:NSSC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.39 by 5.13 percent. This is a 24.24 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $55.809 mill...
08-24 19:03
AMITYVILLE, N.Y., Aug. 24, 2026 /PRNewswire/ -- NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security equipment, w...
08-24 19:00
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40